{"id":40130,"date":"2017-08-15T06:49:32","date_gmt":"2017-08-15T10:49:32","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=40130"},"modified":"2017-08-15T02:50:16","modified_gmt":"2017-08-15T06:50:16","slug":"xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130","title":{"rendered":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product"},"content":{"rendered":"<p><strong>Xtant Medical Holdings Inc <\/strong><strong>(NYSEMKT:XTNT), <\/strong>an industry leader focusing in the development of medical devices and medicine products has made the much awaited announcement. It revealed that the U.S. Food and Drug Administration had cleared product line extensions for the Calix-C family of cervical interbody cages.<\/p>\n<p>This development will lead to the addition of two larger footprints for use with allograft. The clearance will play a major role towards strengthening the company\u2019s focus in regenerative technologies. It will thus help offer more comprehensive and integrated cervical treatment option for medical practitioners and their patients.<\/p>\n<p>Dr. Gregory Juda, the CSO and GM of Xtant Medical. <a href=\"https:\/\/finance.yahoo.com\/news\/xtant-medical-receives-fda-clearance-113000619.html\" target=\"_blank\" rel=\"noopener\">Opined<\/a>, &#8220;This new FDA clearance allows Xtant Medical to leverage the clinical effectiveness of our established allograft product offerings for use with our now expanded line of interbody devices in cervical discectomy and fusion procedures.&#8221;<\/p>\n<p>He added that they had been using the product as a combined spinal fusion solution and they were optimistic that it would spark positive outcomes among patients. The Calix\u2010C\u2122 Cervical Interbody Spacer\u00a0will specifically be used with supplemental spinal fixation systems such as Certex Spinal Fixation Systems and the Spider Cervical Plating.<\/p>\n<p>The giant company has given an estimate of the Spider Cervical Plating. It has outlined that it currently stands at $1.3B and growing. The global market for Demineralized Bone Matrix at the moment stands at $485M. Xtant Medical has kick-started collaborative marketing efforts and later this year it will be making preparations for the unveiling of the new Calix-C sizes.<\/p>\n<p>This provider will soon be leveraging on its core competencies in both biologic and non-biologic surgical technologies towards the achievement of business success. Over the years the provider has been hoping to make major steps forward in business. Also, the ability to compete successfully in the global\u00a0orthopedic surgery\u00a0and neurological markets has been at the top of its priorities.<\/p>\n<p>The company\u2019s spokesperson agrees that indeed they have encountered numerous challenges a long the way. However, they have been able to walk over those challenges and the future looks bright.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Xtant Medical Holdings Inc (NYSEMKT:XTNT), an industry leader focusing in the development of medical devices and medicine products has made the much awaited announcement. It [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":40139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12830,12829,12828],"stock_ticker":[],"class_list":["post-40130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nysemktxtnt","tag-xtant-medical-holdings-inc","tag-xtant-medical-holdings-inc-nysemktxtnt","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Xtant Medical Holdings Inc (NYSEMKT:XTNT), an industry leader focusing in the development of medical devices and medicine products has made the much awaited announcement. It [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-15T10:49:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fiona Gibson\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fiona Gibson\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\"},\"author\":{\"name\":\"Fiona Gibson\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\"},\"headline\":\"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product\",\"datePublished\":\"2017-08-15T10:49:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\"},\"wordCount\":359,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg\",\"keywords\":[\"NYSEMKT:XTNT\",\"Xtant Medical Holdings Inc\",\"Xtant Medical Holdings Inc (NYSEMKT:XTNT)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\",\"name\":\"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg\",\"datePublished\":\"2017-08-15T10:49:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e\",\"name\":\"Fiona Gibson\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg\",\"caption\":\"Fiona Gibson\"},\"description\":\"Fiona is a finance graduate and an expert in analyzing market trends.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\",\"https:\/\/x.com\/@fionahime\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130","og_locale":"en_US","og_type":"article","og_title":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR","og_description":"Xtant Medical Holdings Inc (NYSEMKT:XTNT), an industry leader focusing in the development of medical devices and medicine products has made the much awaited announcement. It [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-08-15T10:49:32+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg","type":"image\/jpeg"}],"author":"Fiona Gibson","twitter_misc":{"Written by":"Fiona Gibson","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130"},"author":{"name":"Fiona Gibson","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e"},"headline":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product","datePublished":"2017-08-15T10:49:32+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130"},"wordCount":359,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg","keywords":["NYSEMKT:XTNT","Xtant Medical Holdings Inc","Xtant Medical Holdings Inc (NYSEMKT:XTNT)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130","url":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130","name":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg","datePublished":"2017-08-15T10:49:32+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/08\/40138-maxresdefault.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/xtant-medical-holdings-inc-nysemktxtnt-receives-fda-clearance-for-its-latest-product-40130#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Xtant Medical Holdings Inc (NYSEMKT:XTNT) Receives FDA Clearance For Its Latest Product"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/e5ef7ff4b449e42e0b2e812283dba24e","name":"Fiona Gibson","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f92ca1ce6ecdb59f7bac42afaacd292b.jpeg","caption":"Fiona Gibson"},"description":"Fiona is a finance graduate and an expert in analyzing market trends.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr","https:\/\/x.com\/@fionahime"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/fiona-gibson"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=40130"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/40130\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/40139"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=40130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=40130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=40130"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=40130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}